Arterial thrombo-embolic events are common in cardiac amyloidosis even in the absence of atrial fibrillation or presence of anticoagulation, suggesting the CHA2DS2-VASc score could be useful for risk stratification in sinus rhythm patients.
Answers are grounded in this paper and cite their sources.
May support CHA2DS2-VASc for risk stratification in sinus-rhythm amyloidosis; hypothesis-generating and requires prospective validation before practice change.
In our large, multicentric, real-world cohort, prevalence and incidence rate of AEs was high. A consistent proportion of events occurred despite anticoagulation therapy or in patients in sinus rhythm. A higher CHA2DS2-VASc score might identify patients at risk of AEs also among those in sinus rhythm.
No takes yet. Share an insight, caveat, or question.
Cappelli et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: